BBOT
BridgeBio Oncology Therapeutics, Inc.
+0.27 (+5.67%)5.03USD185K成交股數403M市值–本益比(近四季)27.1股價營收比+113.2%營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | 09-14 | Cobo Marc | Principal Accounting Officer | A 獲配股票 | 9.0K | – | – | 14.3K | SEC |
| 2026-09-10 | 09-14 | Cobo Marc | Principal Accounting Officer | F 繳稅扣股 | 203 | 5.52 | 1K | 14.1K | SEC |
| 2026-07-01 | 07-06 | Beltran Pedro | President and CEO | F 繳稅扣股 | 1.0K | 7.80 | 8K | 44.6K | SEC |
| 2026-07-01 | 07-06 | Ben Yong | Chief Med & Dev Officer | F 繳稅扣股 | 1.0K | 7.80 | 8K | 44.6K | SEC |
| 2026-07-01 | 07-06 | Chen Bihua | Director,TenPercentOwner | J 其他 | 4.5M | – | – | 0 | SEC |
| 2026-07-01 | 07-06 | Chen Bihua | Director,TenPercentOwner | J 其他 | 2.7M | – | – | 4.9M | SEC |
| 2026-07-01 | 07-06 | Chen Bihua | Director,TenPercentOwner | J 其他 | 1.7M | – | – | 5.0M | SEC |
| 2026-07-01 | 07-06 | Chen Bihua | Director,TenPercentOwner | J 其他 | 131K | – | – | 6.1M | SEC |
| 2026-07-01 | 07-06 | Cobo Marc | Principal Accounting Officer | F 繳稅扣股 | 125 | 7.80 | 975.00 | 5.3K | SEC |
| 2026-07-01 | 07-06 | Elmelech Idan | COO & Principal Financial Ofcr | F 繳稅扣股 | 343 | 7.80 | 3K | 14.5K | SEC |
| 2026-04-01 | 05-05 | Mehra Uneek | Other | F 繳稅扣股 | 524 | 9.03 | 5K | 22.8K | SEC |
| 2026-04-01 | 05-05 | Beltran Pedro | President and CEO | F 繳稅扣股 | 1.0K | 9.03 | 9K | 45.6K | SEC |
| 2026-04-01 | 05-05 | Ben Yong | Chief Med & Dev Officer | F 繳稅扣股 | 1.0K | 9.03 | 9K | 45.6K | SEC |
| 2026-03-10 | 03-12 | Ben Yong | Chief Med & Dev Officer | A 獲配股票 | 46.7K | – | – | 46.7K | SEC |
| 2026-03-10 | 03-12 | Beltran Pedro | Chief Scientific Officer | A 獲配股票 | 46.7K | – | – | 46.7K | SEC |
| 2026-03-10 | 03-12 | Mehra Uneek | Chief Financial Officer | A 獲配股票 | 23.3K | – | – | 23.3K | SEC |
| 2025-10-10 | 10-16 | BridgeBio Pharma, Inc. | TenPercentOwner | J 其他 | 785K | – | – | 14.6M | SEC |
| 2025-10-10 | 10-16 | BridgeBio Pharma LLC | TenPercentOwner | J 其他 | 785K | – | – | 14.6M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | M 選擇權執行 | 4.2M | – | – | 4.7M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | D 處分 | 153K | – | – | 4.5M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 760K | 10.72 | 8.2M | 2.2M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 639K | 10.72 | 6.9M | 1.5M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 5.6M | 10.72 | 60.0M | 5.7M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 1.9M | – | – | 1.9M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 1.8M | – | – | 3.3M | SEC |
| 2025-08-11 | 08-13 | Chen Bihua | Director,TenPercentOwner | A 獲配股票 | 285K | – | – | 6.0M | SEC |
| 2025-08-11 | 08-11 | Schmid John P. | Other | M 選擇權執行 | 30.0K | – | – | 30.0K | SEC |
| 2025-08-11 | 08-11 | McKenna Mark C. | Other | M 選擇權執行 | 30.0K | – | – | 30.0K | SEC |
| 2025-08-11 | 08-11 | Holman Albert A III | Other | M 選擇權執行 | 30.0K | – | – | 30.0K | SEC |
| 2024-02-13 | 02-13 | Helix Holdings II LLC | Director,TenPercentOwner | A 獲配股票 | 509K | 10.00 | 5.1M | 509K | SEC |
| 2024-02-13 | 02-13 | Chen Bihua | CEO and Chairperson | A 獲配股票 | 509K | 10.00 | 5.1M | 509K | SEC |
| 2024-02-13 | 02-13 | Chen Bihua | CEO and Chairperson | P 公開市場買進 | 69.4K | 10.00 | 694K | 69.4K | SEC |
| 2024-02-13 | 02-13 | Chen Bihua | CEO and Chairperson | P 公開市場買進 | 1.4M | 10.00 | 14.3M | 1.4M | SEC |
| 2024-02-13 | 02-13 | Chen Bihua | CEO and Chairperson | P 公開市場買進 | 904K | 10.00 | 9.0M | 904K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.9M | 136M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4.9M | 37.2M | 新進 | 新進 |
| Omega Fund Management, LLC | 3.3M | 25.1M | 新進 | 新進 |
| EcoR1 Capital, LLC | 2.8M | 21.5M | 新進 | 新進 |
| Alphabet Inc. | 2.8M | 21.5M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.8M | 21.3M | 新進 | 新進 |
| ENAVATE SCIENCES GP, LLC | 2.6M | 20.0M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 2.6M | 19.9M | 新進 | 新進 |
| NOVO HOLDINGS A/S | 2.3M | 17.1M | 新進 | 新進 |
| BlackRock, Inc. | 2.2M | 16.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 15.3M | 新進 | 新進 |
| Laurion Capital Management LP | 2.0M | 15.3M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 1.8M | 13.4M | 新進 | 新進 |
| STATE STREET CORP | 1.0M | 7.9M | 新進 | 新進 |
| Aisling Capital Management LP | 1.0M | 7.8M | 新進 | 新進 |
| Opaleye Management Inc. | 700K | 5.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 622K | 4.7M | 新進 | 新進 |
| Granahan Investment Management, LLC | 559K | 4.3M | 新進 | 新進 |
| SPHERA FUNDS MANAGEMENT LTD. | 461K | 3.5M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400K | 3.0M | 新進 | 新進 |
| ROYCE & ASSOCIATES LP | 385K | 2.9M | 新進 | 新進 |
| Catalio Capital Management, LP | 318K | 2.4M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 292K | 2.2M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 287K | 2.2M | 新進 | 新進 |
| Casdin Capital, LLC | 282K | 2.2M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 66 -1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 66 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 59.1M · 73.8% |
| 合計季末市值 | 448M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.2M |
|---|---|
| 與上期比 | +6.6% |
| 佔流通股數 | 7.73% |
| 日均成交量 | 298K |
| 回補天數 | 20.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.2M | +6.6% | 7.73% | 298K | 20.8 |
| 2026-08-14 | 5.8M | -0.3% | 7.24% | 234K | 24.8 |
| 2026-07-31 | 5.8M | +2.4% | 7.27% | 281K | 20.8 |
| 2026-07-15 | 5.7M | +9.1% | 7.10% | 451K | 12.6 |
| 2026-06-30 | 5.2M | +32.3% | 6.50% | 726K | 7.2 |
| 2026-06-15 | 3.9M | +1.9% | 4.91% | 252K | 15.7 |
| 2026-05-29 | 3.9M | +18.1% | 4.82% | 464K | 8.3 |
| 2026-05-15 | 3.3M | -1.4% | 4.09% | 324K | 10.1 |
| 2026-04-30 | 3.3M | +2.6% | 4.14% | 548K | 6.1 |
| 2026-04-15 | 3.2M | +35.2% | 4.04% | 446K | 7.3 |
| 2026-03-31 | 2.4M | +6.1% | 2.99% | 126K | 19.0 |
| 2026-03-13 | 2.3M | -3.1% | 2.81% | 193K | 11.7 |
| 2026-02-27 | 2.3M | -0.6% | 2.90% | 298K | 7.8 |
| 2026-02-13 | 2.3M | +8.4% | 2.92% | 282K | 8.3 |
| 2026-01-30 | 2.2M | -1.1% | 2.69% | 249K | 8.7 |
| 2026-01-15 | 2.2M | +18.4% | 2.72% | 500K | 4.4 |
| 2025-12-31 | 1.8M | +23.1% | 2.30% | 168K | 11.0 |
| 2025-12-15 | 1.5M | +32.8% | 1.87% | 209K | 7.2 |
| 2025-11-28 | 1.1M | +15.6% | 1.41% | 134K | 8.4 |
| 2025-11-14 | 977K | +19.8% | 1.22% | 118K | 8.3 |
| 2025-10-31 | 816K | +6.9% | 1.02% | 146K | 5.6 |
| 2025-10-15 | 763K | -31.0% | 0.95% | 217K | 3.5 |
| 2025-09-30 | 1.1M | +1317.2% | 1.38% | 528K | 2.1 |
| 2025-09-15 | 78.1K | +42.8% | 0.10% | 246K | 1.0 |
| 2025-08-29 | 54.7K | +25.8% | 0.07% | 182K | 1.0 |
| 2025-08-15 | 43.5K | +213.5% | 0.05% | 120K | 1.0 |